Boosting axitinib exposure with a CYP3A4 inhibitor, making axitinib treatment personal.

Related Articles

Boosting axitinib exposure with a CYP3A4 inhibitor, making axitinib treatment personal.

Acta Oncol. 2017 Apr 07;:1-3

Authors: Lubberman FJ, van Erp NP, Ter Heine R, van Herpen CM

PMID: 28388255 [PubMed - as supplied by publisher]

from Head and Neck on PubMed via xlomafota13 on Inoreader http://ift.tt/2o9frYy


http://ift.tt/2oN5D9M